Humex Conjonctivite Allergique

Humex Conjonctivite Allergique is an ophthalmic preparation that contains the mast‑cell stabilizer sodium cromoglicate. Marketed in the European Union, it is formulated for ocular use to address allergic inflammation of the conjunctiva. The product belongs to the antiallergic (ophthalmic) therapeutic class and carries ATC code D02AB02. It works locally on the eye surface without systemic absorption, providing short‑term relief of itching, redness, and tearing and discomfort.

Humex Conjonctivite Allergique is indicated for the treatment of allergic conjunctivitis, a condition characterized by ocular itching, redness, and watery discharge. - Relief of ocular itching caused by seasonal or perennial allergens such as pollen, dust mites, or animal dander. - Reduction of conjunctival redness and swelling associated with allergic inflammation. - Decrease in tear production and watery discharge that accompany allergic episodes. - Management of mild to moderate allergic eye symptoms when antihistamine eye drops alone are insufficient. - Adjunctive therapy for patients with a history of mast‑cell mediated ocular reactions, supporting other antiallergic measures.

Adverse ocular reactions reported with sodium cromoglicate eye drops are generally mild, but rare serious events have been described. Common: - Transient stinging or burning sensation upon instillation, usually lasting seconds to a minute. - Temporary blurred vision that resolves within a few minutes without intervention. - Mild conjunctival hyperemia (redness) that is not related to the underlying allergy. - Slight increase in tear production immediately after dosing, which normalizes quickly. - Mild eyelid swelling without systemic involvement, typically resolving spontaneously. Serious: - Persistent ocular irritation or pain lasting more than 24 hours and not improving with standard measures. - Signs of allergic contact dermatitis affecting the eyelids or peri‑ocular skin, such as redness, itching, or rash.

When using Humex Conjonctivite Allergique, certain precautions should be observed to ensure safety and optimal therapeutic effect. - Do not use if you are hypersensitive to sodium cromoglicate or any formulation ingredients. - Avoid touching the drop tip to the eye or surrounding tissue to prevent contamination. - Stop using and seek medical advice if symptoms worsen or fail to improve after a reasonable period. - Keep out of reach of children; accidental ingestion may cause gastrointestinal upset. - Store at room temperature, protected from light, and discard after the expiration date.

Sodium cromoglicate eye drops have a low potential for systemic drug interactions, but certain combinations may affect safety or efficacy. Avoid: - Concurrent use with ophthalmic solutions containing preservatives that may increase ocular irritation. - Simultaneous administration of other mast‑cell stabilizers in the same eye, which can lead to additive local effects. Use with caution: - Antihistamine eye drops; spacing applications by at least 5 minutes can minimize potential antagonism. - Non‑steroidal anti‑inflammatory eye drops, as combined use may increase the risk of corneal irritation. - Contact lens wear; lenses should be removed before instillation and reinserted after a suitable interval. - Topical ocular antibiotics; no known interaction but monitor for overlapping irritation.